Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial

Documenti analoghi

• Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
  di: Andrew Blumenfeld, et al.
  Pubblicazione: (2024)
• No differences in subcortical volume between people with and without migraine: A REFORM study
  di: Basit Ali Chaudhry, et al.
  Pubblicazione: (2025)
• The impact of headache intensity on speech in participants with migraine and acute post‐traumatic headache
  di: Dani C. Smith, et al.
  Pubblicazione: (2024)
• What's in the pipeline for pediatric headache treatment?
  di: Amy A. Gelfand, et al.
  Pubblicazione: (2025)
• Sequential administration of peripheral nerve blocks and  onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
  di: Christopher C. Anderson, et al.
  Pubblicazione: (2024)